Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.0K
Overview
83.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Brain Network Connectivity Predicts Survival in Diffuse Midline Glioma.

Cancer discovery·2026
Same journal

First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

Cancer discovery·2026
Same journal

CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

Cancer discovery·2026
Same journal

CDK8 inhibition induces Mediator trapping and impairment of the EWSR1::FLI1 transcriptional program in Ewing sarcoma.

Cancer discovery·2026
Same journal

SEZ6-Targeted ADC Shows Preliminary Efficacy in Small Cell Lung Cancer.

Cancer discovery·2026
Same journal

Nonprofit Acquires Abandoned Leukemia Drug Supply.

Cancer discovery·2026

Related Experiment Video

Updated: Dec 25, 2025

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

1.3K

A Previously Unknown Dendritic Cell Type Reduces Antitumor Response

    Cancer Discovery
    |April 5, 2020
    PubMed
    Summary

    A specific cluster of dendritic cells, known as mregDCs, were found to limit the body's natural defense against tumors in both humans and mice. This discovery sheds light on a new mechanism suppressing anti-cancer immune responses.

    Area of Science:

    • Immunology
    • Cancer Research
    • Cell Biology

    Background:

    • Antitumor immunity is crucial for preventing cancer progression.
    • Dendritic cells play a key role in initiating and regulating immune responses.
    • Understanding suppressive immune cells is vital for developing effective cancer therapies.

    Purpose of the Study:

    • To investigate the role of a specific dendritic cell subset in regulating antitumor immunity.
    • To identify novel cellular mechanisms that restrict anti-cancer immune responses.

    Main Methods:

    • Identification and characterization of a novel dendritic cell cluster (mregDCs) in human and murine models.
    • Analysis of mregDC function in the context of tumor immunity.

    Main Results:

    More Related Videos

    An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
    09:09

    An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets

    Published on: April 18, 2016

    15.8K
    Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
    11:48

    Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

    Published on: May 31, 2018

    11.9K

    Related Experiment Videos

    Last Updated: Dec 25, 2025

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
    10:04

    Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

    Published on: August 1, 2025

    1.3K
    An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
    09:09

    An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets

    Published on: April 18, 2016

    15.8K
    Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
    11:48

    Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

    Published on: May 31, 2018

    11.9K
    • A distinct cluster of dendritic cells, termed mregDCs, was identified in both humans and mice.
    • These mregDCs were found to restrict antitumor immune responses, acting as a barrier to the body's natural defenses against cancer.

    Conclusions:

    • mregDCs represent a previously unrecognized suppressive cell population within the tumor microenvironment.
    • Targeting mregDCs may offer a novel therapeutic strategy to enhance antitumor immunity and improve cancer treatment outcomes.